Back to Search
Start Over
Quality prescribing in early psychosis: key pharmacotherapy principles.
- Source :
-
Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists [Australas Psychiatry] 2022 Jun; Vol. 30 (3), pp. 341-345. Date of Electronic Publication: 2021 Nov 08. - Publication Year :
- 2022
-
Abstract
- Objective: To present a practical, easy-to-implement clinical framework designed to support evidence-based quality prescribing for people with early psychosis.<br />Method: Identification and explanation of key principles relating to evidence-based pharmacotherapy for people with early psychosis. These were derived from the literature, practice guidelines and clinical experience.<br />Results: Key principles include (1) medication choice informed by adverse effects; (2) metabolic monitoring at baseline and at regular intervals; (3) comprehensive and regular medication risk-benefit assessment and psychoeducation; (4) early consideration of long-acting injectable formulations (preferably driven by informed patient choice); (5) identification and treatment of comorbid mood disorders and (6) early consideration of clozapine when treatment refractory criteria are met.<br />Conclusions: Current prescribing practices do not align with the well-established evidence for quality pharmacotherapy in early psychosis. Adopting evidence-based prescribing practices for people with early psychosis will improve outcomes.
Details
- Language :
- English
- ISSN :
- 1440-1665
- Volume :
- 30
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists
- Publication Type :
- Academic Journal
- Accession number :
- 34748711
- Full Text :
- https://doi.org/10.1177/10398562211054656